naphazoline hydrochloride 0.5 MG/ML Nasal Spray
- RxCUI
- 1046610
- RxNorm name
- naphazoline hydrochloride 0.5 MG/ML Nasal Spray
- Display name
- Naphazoline (Nasal)
- Full name
- naphazoline hydrochloride 0.5 MG/ML Nasal Spray
- Term type
- SCD
- Status
- Active
- Strength
- 0.05%
- Dose form
- Spray
- Route
- Nasal
- Updated
- 2026-06-15 06:59:38
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122010
- Active start
- 122010
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| naphazoline hydrochloride | 0.5 MG / 1 ML | naphazoline | naphazoline hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Nasal Spray | 126542 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| naphazoline | 7247 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | NAMES |
| RxNorm Name | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | NAMES |
| RxNorm Synonym | naphazoline HCl 0.05 % Nasal Spray | NAMES |
| TTY | SCD | ATTRIBUTES |
| SPL_SET_ID | 4a208a1f-f6e8-0b4a-e063-6294a90a10c8 | CODES |
| SPL_SET_ID | 4a470b9e-c83f-fb20-e063-6294a90a2f13 | CODES |
| SPL_SET_ID | 4a4abdc0-aded-1b8a-e063-6394a90a9b56 | CODES |
| SPL_SET_ID | 4a4d0c03-7d8f-76cb-e063-6394a90a938c | CODES |
| SPL_SET_ID | 4a4d3a2b-a4ed-c736-e063-6394a90a96df | CODES |
| RxCUI | 1046610 | CODES |
| MMSL_CODE | CD6058 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 85248-053-01 | 85248-053 | SKAPEMED ORIGINAL NASAL Naphazoline HCL 0.05% ORIGINAL NASAL | Jiangxi Yudexi Pharmaceutical Co., LTD | M012 |
| 85248-083-01 | 85248-083 | NATUHEAL ORIGINAL NASAL Naphazoline HCL 0.05% ORIGINAL NASAL | Jiangxi Yudexi Pharmaceutical Co., LTD | M012 |
| 85248-099-01 | 85248-099 | SERYNTH FAST RELIEF NASAL Naphazoline HCL 0.05% FAST RELIEF NASAL | Jiangxi Yudexi Pharmaceutical Co., LTD | M012 |
| 85248-111-01 | 85248-111 | DERMFREE ORIGINAL NASAL Naphazoline HCL0.05%ORIGINAL NASAL | Jiangxi Yudexi Pharmaceutical Co., LTD | M012 |
| 85248-112-01 | 85248-112 | DERMFREE ORIGINAL NASAL Naphazoline HCL 0.05%ORIGINAL NASAL | Jiangxi Yudexi Pharmaceutical Co., LTD | M012 |
Drugs@FDA Applications#
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4a4abdc0-aded-1b8a-e063-6394a90a9b56 | naphazoline HCl 0.05 % Nasal Spray | SY | 1 | 85248-099 | 20260208 |
| 4a4abdc0-aded-1b8a-e063-6394a90a9b56 | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 1 | 85248-099 | 20260208 |
| 4a4abdc0-aded-1b8a-e063-6394a90a9b56 | naphazoline HCl 0.05 % Nasal Spray | PSN | 1 | 85248-099 | 20260208 |
| 4a4d0c03-7d8f-76cb-e063-6394a90a938c | naphazoline HCl 0.05 % Nasal Spray | SY | 1 | 85248-111 | 20260208 |
| 4a4d0c03-7d8f-76cb-e063-6394a90a938c | naphazoline HCl 0.05 % Nasal Spray | PSN | 1 | 85248-111 | 20260208 |
| 4a4d0c03-7d8f-76cb-e063-6394a90a938c | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 1 | 85248-111 | 20260208 |
| 4a4d3a2b-a4ed-c736-e063-6394a90a96df | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 1 | 85248-112 | 20260208 |
| 4a4d3a2b-a4ed-c736-e063-6394a90a96df | naphazoline HCl 0.05 % Nasal Spray | PSN | 1 | 85248-112 | 20260208 |
| 4a4d3a2b-a4ed-c736-e063-6394a90a96df | naphazoline HCl 0.05 % Nasal Spray | SY | 1 | 85248-112 | 20260208 |
| 4a470b9e-c83f-fb20-e063-6294a90a2f13 | naphazoline HCl 0.05 % Nasal Spray | SY | 1 | 85248-083 | 20260207 |
| 4a470b9e-c83f-fb20-e063-6294a90a2f13 | naphazoline HCl 0.05 % Nasal Spray | PSN | 1 | 85248-083 | 20260207 |
| 4a470b9e-c83f-fb20-e063-6294a90a2f13 | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 1 | 85248-083 | 20260207 |
| 4a208a1f-f6e8-0b4a-e063-6294a90a10c8 | naphazoline HCl 0.05 % Nasal Spray | SY | 1 | 85248-053 | 20260205 |
| 4a208a1f-f6e8-0b4a-e063-6294a90a10c8 | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 1 | 85248-053 | 20260205 |
| 4a208a1f-f6e8-0b4a-e063-6294a90a10c8 | naphazoline HCl 0.05 % Nasal Spray | PSN | 1 | 85248-053 | 20260205 |
| ec2bb7d7-d014-46ed-a836-453e921da4c5 | naphazoline HCl 0.05 % Nasal Spray | PSN | 1 | Privine ® nasal spray | 20090731 |
| ec2bb7d7-d014-46ed-a836-453e921da4c5 | naphazoline HCl 0.05 % Nasal Spray | SY | 1 | Privine ® nasal spray | 20090731 |
| ec2bb7d7-d014-46ed-a836-453e921da4c5 | naphazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 1 | Privine ® nasal spray | 20090731 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 4a4abdc0-aded-1b8a-e063-6394a90a9b56 | 85248-099 | Jiangxi Yudexi Pharmaceutical Co., LTD | 20260208 |
| 4a4d0c03-7d8f-76cb-e063-6394a90a938c | 85248-111 | Jiangxi Yudexi Pharmaceutical Co., LTD | 20260208 |
| 4a4d3a2b-a4ed-c736-e063-6394a90a96df | 85248-112 | Jiangxi Yudexi Pharmaceutical Co., LTD | 20260208 |
| 4a470b9e-c83f-fb20-e063-6294a90a2f13 | 85248-083 | Jiangxi Yudexi Pharmaceutical Co., LTD | 20260207 |
| 4a208a1f-f6e8-0b4a-e063-6294a90a10c8 | 85248-053 | Jiangxi Yudexi Pharmaceutical Co., LTD | 20260205 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | naphazoline | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | naphazoline | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | naphazoline | |
| MEDRT | D009278 | Naphazoline | CHEM | has_ingredient | naphazoline |
| MEDRT | D009278 | Naphazoline | CHEM | has_ingredient | naphazoline hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naphazoline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naphazoline hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | naphazoline hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | naphazoline |
| MEDRT | D006940 | Hyperemia | DISEASE | may_treat | naphazoline |
| MEDRT | D006940 | Hyperemia | DISEASE | may_treat | naphazoline hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | naphazoline hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | naphazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | naphazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | naphazoline hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | naphazoline |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | naphazoline hydrochloride |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | naphazoline |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | naphazoline hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | naphazoline |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | naphazoline hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SCD |
| CODES | MMSL_CODE | CD6058 |
| CODES | RxCUI | 1046610 |
| CODES | SPL_SET_ID | 4a208a1f-f6e8-0b4a-e063-6294a90a10c8 |
| CODES | SPL_SET_ID | 4a470b9e-c83f-fb20-e063-6294a90a2f13 |
| CODES | SPL_SET_ID | 4a4abdc0-aded-1b8a-e063-6394a90a9b56 |
| CODES | SPL_SET_ID | 4a4d0c03-7d8f-76cb-e063-6394a90a938c |
| CODES | SPL_SET_ID | 4a4d3a2b-a4ed-c736-e063-6394a90a96df |
| NAMES | Prescribable Synonym | naphazoline HCl 0.05 % Nasal Spray |
| NAMES | RXNAV_STR | naphazoline hydrochloride 0.5 MG/ML Nasal Spray |
| NAMES | RxNorm Name | naphazoline hydrochloride 0.5 MG/ML Nasal Spray |
| NAMES | RxNorm Synonym | naphazoline HCl 0.05 % Nasal Spray |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |